RTP: "Infarmed has just approved public funding for the first drug containing ketamine, a psychedelic, to be used in hospital settings for adults with severe depression."
According to RTP, the decision appliesto a patients who did not responded a at least at least three different treatments with antidepressants. Scetamine (spravat) will be used in combined with an SSRI or NRTI, in depressive depressive moderate a severe, especially in cases where resistance resistance or contraindication à electroconvulsive therapy, or when electroconvulsive is not is accessible or has refused.
At The Clinic of Change there is a treatment program with scetamine (Spravato) which you can consult here.
Read the full article here.
Discover our treatment programs - Consultations and Programs - The Clinic of Change.
